Ironwood Pharma's total assets for Q4 2025 were $396.90M, an increase of 0.21% from the previous quarter. IRWD total liabilities were $658.74M for the fiscal quarter, a -0.22% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.